To find the most relevant journal, please insert appropriate keyword to facilitate search.
Search Results: cdt
Current Drug Targets
ISSN: 1389-4501 (Print)
eISSN: 1873-5592 (Online)
Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication full-length/mini review articles and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Special Issues With Active Call for Papers
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical database, provides data on approximately 119 million compounds from 1,005 data sources (as of August 2024). Nevertheless, it is estimated that the pool of drug-like... see more
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at which drugs are released, enhance the bioavailability of medicines, and selectively target particular cells or tissues. Consequently, this approach enhances the therapeutic effectiveness of pharmaceutical... see more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response, and/or therapy efficacy monitoring. Moreover, RNA molecules constitute important drug targets that can be used as drugs against a wide range of human diseases. This thematic issue... see more